+91-22-489139092019 এর সেরা ইক্যুইটি মিউচুয়াল তহবিল
ইক্যুইটি তহবিল তারাই যাদের সঞ্চিত তহবিলের অর্থ বিভিন্ন সংস্থার ইক্যুইটি এবং ইক্যুইটি-সম্পর্কিত যন্ত্রগুলিতে বিনিয়োগ করা হয়। ইক্যুইটি তহবিলগুলিকে মধ্যপন্থী এবং উচ্চ- এমন লোকের জন্য দীর্ঘমেয়াদী বিনিয়োগের বিকল্প হিসাবে বিবেচনা করা হয়ঝুকিপুন্ন ক্ষুধা। ইক্যুইটি তহবিল বিভিন্ন বিভাগ অন্তর্ভুক্তবড় ক্যাপ ফান্ড,মিড ক্যাপ তহবিল,ছোট ক্যাপ ফান্ড,ELSS, ইত্যাদি। ২০১২ সালে, ইক্যুইটি মার্কেটে উত্থান দেখা গেছে যার কারণে বেশিরভাগ ইক্যুইটি ফান্ডের বিভাগগুলি ভাল পারফর্ম করেছে। এই তহবিলগুলির কার্যকারিতা অনেকগুলি ম্যাক্রো এবং মাইক্রোকোনমিক প্যারামিটারের উপর নির্ভর করে যেমন শিল্পের পারফরম্যান্স, কোম্পানির কর্মক্ষমতা, সংস্থাগুলির উপার্জন এবং লাভ, তার ভবিষ্যতের সম্ভাব্যতা ইত্যাদি। শীর্ষ এবংসেরা ইক্যুইটি তহবিল নিম্নলিখিত বছরের জন্য 2019।
Talk to our investment specialist
পারফরম্যান্সের ভিত্তিতে 2019 এর শীর্ষ 10 ইক্যুইটি মিউচুয়াল তহবিল
Fund NAV Net Assets (Cr) 2024 (%) 2023 (%) 2022 (%) 2021 (%) 2020 (%) Motilal Oswal Midcap 30 Fund Growth ₹104.084
↓ -0.42 ₹33,609 57.1 41.7 10.7 55.8 9.3 LIC MF Infrastructure Fund Growth ₹48.4869
↑ 0.06 ₹1,038 47.8 44.4 7.9 46.6 -0.1 Motilal Oswal Long Term Equity Fund Growth ₹50.7266
↓ -0.13 ₹4,402 47.7 37 1.8 32.1 8.8 Motilal Oswal Multicap 35 Fund Growth ₹62.3262
↓ -0.17 ₹13,727 45.7 31 -3 15.3 10.3 Invesco India Mid Cap Fund Growth ₹180.34
↑ 0.78 ₹7,802 43.1 34.1 0.5 43.1 24.4 UTI Healthcare Fund Growth ₹293.129
↑ 0.60 ₹1,146 42.9 38.2 -12.3 19.1 67.4 SBI Healthcare Opportunities Fund Growth ₹432.494
↑ 0.13 ₹4,027 42.2 38.2 -6 20.1 65.8 TATA India Pharma & Healthcare Fund Growth ₹30.7696
↓ -0.03 ₹1,339 40.4 36.6 -8 19.1 64.4 IDBI Small Cap Fund Growth ₹30.2874
↑ 0.09 ₹618 40 33.4 2.4 64.7 19 Bandhan Infrastructure Fund Growth ₹49.237
↓ -0.08 ₹1,676 39.3 50.3 1.7 64.8 6.3 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 5 Sep 25 Research Highlights & Commentary of 10 Funds showcased
Commentary Motilal Oswal Midcap 30 Fund LIC MF Infrastructure Fund Motilal Oswal Long Term Equity Fund Motilal Oswal Multicap 35 Fund Invesco India Mid Cap Fund UTI Healthcare Fund SBI Healthcare Opportunities Fund TATA India Pharma & Healthcare Fund IDBI Small Cap Fund Bandhan Infrastructure Fund Point 1 Highest AUM (₹33,609 Cr). Bottom quartile AUM (₹1,038 Cr). Upper mid AUM (₹4,402 Cr). Top quartile AUM (₹13,727 Cr). Upper mid AUM (₹7,802 Cr). Bottom quartile AUM (₹1,146 Cr). Upper mid AUM (₹4,027 Cr). Lower mid AUM (₹1,339 Cr). Bottom quartile AUM (₹618 Cr). Lower mid AUM (₹1,676 Cr). Point 2 Established history (11+ yrs). Established history (17+ yrs). Established history (10+ yrs). Established history (11+ yrs). Established history (18+ yrs). Oldest track record among peers (26 yrs). Established history (20+ yrs). Established history (9+ yrs). Established history (8+ yrs). Established history (14+ yrs). Point 3 Rating: 3★ (upper mid). Not Rated. Not Rated. Top rated. Rating: 2★ (upper mid). Rating: 1★ (lower mid). Rating: 2★ (upper mid). Not Rated. Not Rated. Rating: 5★ (top quartile). Point 4 Risk profile: Moderately High. Risk profile: High. Risk profile: Moderately High. Risk profile: Moderately High. Risk profile: Moderately High. Risk profile: High. Risk profile: High. Risk profile: High. Risk profile: Moderately High. Risk profile: High. Point 5 5Y return: 33.49% (top quartile). 5Y return: 30.80% (upper mid). 5Y return: 24.97% (lower mid). 5Y return: 19.79% (bottom quartile). 5Y return: 28.10% (upper mid). 5Y return: 19.06% (bottom quartile). 5Y return: 20.97% (lower mid). 5Y return: 19.32% (bottom quartile). 5Y return: 27.90% (upper mid). 5Y return: 32.27% (top quartile). Point 6 3Y return: 27.60% (top quartile). 3Y return: 26.16% (upper mid). 3Y return: 24.23% (lower mid). 3Y return: 22.38% (bottom quartile). 3Y return: 26.92% (top quartile). 3Y return: 25.74% (lower mid). 3Y return: 26.66% (upper mid). 3Y return: 23.80% (bottom quartile). 3Y return: 16.69% (bottom quartile). 3Y return: 25.86% (upper mid). Point 7 1Y return: 0.60% (upper mid). 1Y return: -6.91% (bottom quartile). 1Y return: -3.41% (lower mid). 1Y return: 3.55% (upper mid). 1Y return: 8.65% (top quartile). 1Y return: 2.65% (upper mid). 1Y return: 5.02% (top quartile). 1Y return: -1.06% (lower mid). 1Y return: -10.56% (bottom quartile). 1Y return: -11.70% (bottom quartile). Point 8 Alpha: 3.70 (upper mid). Alpha: 1.35 (lower mid). Alpha: 11.36 (top quartile). Alpha: 10.18 (top quartile). Alpha: 0.00 (bottom quartile). Alpha: 0.67 (lower mid). Alpha: 3.04 (upper mid). Alpha: 2.48 (upper mid). Alpha: -3.30 (bottom quartile). Alpha: 0.00 (bottom quartile). Point 9 Sharpe: -0.11 (lower mid). Sharpe: -0.30 (bottom quartile). Sharpe: 0.04 (lower mid). Sharpe: 0.11 (upper mid). Sharpe: 0.32 (upper mid). Sharpe: 0.43 (top quartile). Sharpe: 0.60 (top quartile). Sharpe: 0.16 (upper mid). Sharpe: -0.45 (bottom quartile). Sharpe: -0.69 (bottom quartile). Point 10 Information ratio: 0.44 (upper mid). Information ratio: 0.40 (upper mid). Information ratio: 0.92 (top quartile). Information ratio: 0.80 (top quartile). Information ratio: 0.00 (lower mid). Information ratio: -0.06 (bottom quartile). Information ratio: 0.38 (lower mid). Information ratio: 0.60 (upper mid). Information ratio: -0.66 (bottom quartile). Information ratio: 0.00 (bottom quartile). Motilal Oswal Midcap 30 Fund
LIC MF Infrastructure Fund
Motilal Oswal Long Term Equity Fund
Motilal Oswal Multicap 35 Fund
Invesco India Mid Cap Fund
UTI Healthcare Fund
SBI Healthcare Opportunities Fund
TATA India Pharma & Healthcare Fund
IDBI Small Cap Fund
Bandhan Infrastructure Fund
2019 এর শীর্ষ এবং সেরা ইক্যুইটি মিউচুয়াল তহবিল
(Erstwhile Motilal Oswal MOSt Focused Midcap 30 Fund) The investment objective of the Scheme is to achieve long term capital appreciation by investing in a maximum of 30 quality mid-cap companies having long-term competitive advantages and potential for growth. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved. Below is the key information for Motilal Oswal Midcap 30 Fund Returns up to 1 year are on The investment objective of the scheme is to provide long term growth from a portfolio of equity / equity related instruments of companies engaged either directly or indirectly in the infrastructure sector. Research Highlights for LIC MF Infrastructure Fund Below is the key information for LIC MF Infrastructure Fund Returns up to 1 year are on (Erstwhile Motilal Oswal MOSt Focused Long Term Fund) The investment objective of the Scheme is to generate long-term capital appreciation from a diversified portfolio of predominantly equity and equity related instruments. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved. Research Highlights for Motilal Oswal Long Term Equity Fund Below is the key information for Motilal Oswal Long Term Equity Fund Returns up to 1 year are on (Erstwhile Motilal Oswal MOSt Focused Multicap 35 Fund) The investment objective of the Scheme is to achieve long term capital appreciation by primarily investing in a maximum of 35 equity & equity related instruments across sectors and market-capitalization levels.However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved. Research Highlights for Motilal Oswal Multicap 35 Fund Below is the key information for Motilal Oswal Multicap 35 Fund Returns up to 1 year are on The Scheme seeks to provide long term capital appreciation by investing in a portfolio that is predominantly constituted of equity and equity related instruments of mid cap companies. However, there can be no assurance that the funds objectives will be achieved. Research Highlights for Invesco India Mid Cap Fund Below is the key information for Invesco India Mid Cap Fund Returns up to 1 year are on (Erstwhile UTI Pharma & Healthcare Fund) The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors. Research Highlights for UTI Healthcare Fund Below is the key information for UTI Healthcare Fund Returns up to 1 year are on (Erstwhile SBI Pharma Fund) To provide the investors maximum growth opportunity through equity
investments in stocks of growth oriented sectors of the economy. Research Highlights for SBI Healthcare Opportunities Fund Below is the key information for SBI Healthcare Opportunities Fund Returns up to 1 year are on The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns. Research Highlights for TATA India Pharma & Healthcare Fund Below is the key information for TATA India Pharma & Healthcare Fund Returns up to 1 year are on The Investment objective of the Scheme is to provide investors with the opportunities for long-term capital appreciation by investing predominantly in Equity and Equity related instruments of Small Cap companies. However
there can be no assurance that the investment objective under the Scheme will be realized. Research Highlights for IDBI Small Cap Fund Below is the key information for IDBI Small Cap Fund Returns up to 1 year are on The investment objective of the scheme is to seek to generate long-term capital growth through an active diversified portfolio of predominantly equity and equity related instruments of companies that are participating in and benefiting from growth in Indian infrastructure and infrastructural related activities. However, there can be no assurance that the investment objective of the scheme will be realized. Research Highlights for Bandhan Infrastructure Fund Below is the key information for Bandhan Infrastructure Fund Returns up to 1 year are on 1. Motilal Oswal Midcap 30 Fund
Motilal Oswal Midcap 30 Fund
Growth Launch Date 24 Feb 14 NAV (05 Sep 25) ₹104.084 ↓ -0.42 (-0.40 %) Net Assets (Cr) ₹33,609 on 31 Jul 25 Category Equity - Mid Cap AMC Motilal Oswal Asset Management Co. Ltd Rating ☆☆☆ Risk Moderately High Expense Ratio 1.56 Sharpe Ratio -0.11 Information Ratio 0.44 Alpha Ratio 3.7 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Aug 20 ₹10,000 31 Aug 21 ₹16,108 31 Aug 22 ₹20,215 31 Aug 23 ₹25,558 31 Aug 24 ₹41,687 31 Aug 25 ₹41,704 Returns for Motilal Oswal Midcap 30 Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 5 Sep 25 Duration Returns 1 Month 1.3% 3 Month 3.6% 6 Month 14.2% 1 Year 0.6% 3 Year 27.6% 5 Year 33.5% 10 Year 15 Year Since launch 22.5% Historical performance (Yearly) on absolute basis
Year Returns 2024 57.1% 2023 41.7% 2022 10.7% 2021 55.8% 2020 9.3% 2019 9.7% 2018 -12.7% 2017 30.8% 2016 5.2% 2015 16.5% Fund Manager information for Motilal Oswal Midcap 30 Fund
Name Since Tenure Ajay Khandelwal 1 Oct 24 0.92 Yr. Niket Shah 1 Jul 20 5.17 Yr. Rakesh Shetty 22 Nov 22 2.78 Yr. Sunil Sawant 1 Jul 24 1.17 Yr. Data below for Motilal Oswal Midcap 30 Fund as on 31 Jul 25
Equity Sector Allocation
Sector Value Technology 34.22% Industrials 18.95% Consumer Cyclical 16.7% Communication Services 3.85% Health Care 3.7% Financial Services 2.6% Real Estate 2.03% Asset Allocation
Asset Class Value Cash 17.96% Equity 82.04% Top Securities Holdings / Portfolio
Name Holding Value Quantity Dixon Technologies (India) Ltd (Technology)
Equity, Since 31 Mar 23 | DIXON11% ₹3,537 Cr 2,099,999
↑ 100,000 Coforge Ltd (Technology)
Equity, Since 31 Mar 23 | COFORGE9% ₹3,147 Cr 18,000,050
↑ 50 Kalyan Jewellers India Ltd (Consumer Cyclical)
Equity, Since 29 Feb 24 | KALYANKJIL9% ₹2,978 Cr 50,076,240
↑ 5,076,240 Persistent Systems Ltd (Technology)
Equity, Since 31 Jan 23 | PERSISTENT8% ₹2,787 Cr 5,400,005
↑ 150,005 Trent Ltd (Consumer Cyclical)
Equity, Since 30 Nov 24 | 5002518% ₹2,634 Cr 5,250,000
↑ 257,861 Polycab India Ltd (Industrials)
Equity, Since 30 Sep 23 | POLYCAB6% ₹1,876 Cr 2,750,000
↑ 200,000 One97 Communications Ltd (Technology)
Equity, Since 30 Sep 24 | 5433964% ₹1,511 Cr 13,869,997
↑ 3,773,933 KEI Industries Ltd (Industrials)
Equity, Since 30 Nov 24 | KEI4% ₹1,345 Cr 3,500,000 Bharti Hexacom Ltd (Communication Services)
Equity, Since 31 Oct 24 | BHARTIHEXA4% ₹1,293 Cr 7,000,000
↑ 250,000 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Mar 24 | MAXHEALTH4% ₹1,242 Cr 9,969,361 2. LIC MF Infrastructure Fund
LIC MF Infrastructure Fund
Growth Launch Date 29 Feb 08 NAV (05 Sep 25) ₹48.4869 ↑ 0.06 (0.13 %) Net Assets (Cr) ₹1,038 on 31 Jul 25 Category Equity - Sectoral AMC LIC Mutual Fund Asset Mgmt Co Ltd Rating Risk High Expense Ratio 2.21 Sharpe Ratio -0.3 Information Ratio 0.4 Alpha Ratio 1.35 Min Investment 5,000 Min SIP Investment 1,000 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Aug 20 ₹10,000 31 Aug 21 ₹16,396 31 Aug 22 ₹18,753 31 Aug 23 ₹23,082 31 Aug 24 ₹41,121 31 Aug 25 ₹37,159 Returns for LIC MF Infrastructure Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 5 Sep 25 Duration Returns 1 Month -1.4% 3 Month -2.3% 6 Month 18.4% 1 Year -6.9% 3 Year 26.2% 5 Year 30.8% 10 Year 15 Year Since launch 9.4% Historical performance (Yearly) on absolute basis
Year Returns 2024 47.8% 2023 44.4% 2022 7.9% 2021 46.6% 2020 -0.1% 2019 13.3% 2018 -14.6% 2017 42.2% 2016 -2.2% 2015 -6.2% Fund Manager information for LIC MF Infrastructure Fund
Name Since Tenure Yogesh Patil 18 Sep 20 4.96 Yr. Mahesh Bendre 1 Jul 24 1.17 Yr. Data below for LIC MF Infrastructure Fund as on 31 Jul 25
Equity Sector Allocation
Sector Value Industrials 49.62% Basic Materials 8.63% Financial Services 8.16% Consumer Cyclical 6.96% Utility 6.68% Technology 4.17% Health Care 3.87% Real Estate 3.65% Communication Services 2.48% Energy 0.92% Asset Allocation
Asset Class Value Cash 4.87% Equity 95.13% Top Securities Holdings / Portfolio
Name Holding Value Quantity Shakti Pumps (India) Ltd (Industrials)
Equity, Since 31 Mar 24 | SHAKTIPUMP6% ₹62 Cr 693,857
↑ 217,865 Larsen & Toubro Ltd (Industrials)
Equity, Since 30 Apr 09 | LT4% ₹40 Cr 109,584
↑ 6,093 REC Ltd (Financial Services)
Equity, Since 31 Jul 23 | 5329553% ₹36 Cr 911,009
↑ 289,485 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Jun 25 | APOLLOHOSP3% ₹35 Cr 46,843
↑ 6,976 Garware Hi-Tech Films Ltd (Basic Materials)
Equity, Since 31 Aug 23 | 5006553% ₹33 Cr 94,287 Schneider Electric Infrastructure Ltd (Industrials)
Equity, Since 31 Dec 23 | SCHNEIDER3% ₹32 Cr 319,302 Afcons Infrastructure Ltd (Industrials)
Equity, Since 31 Oct 24 | AFCONS3% ₹31 Cr 769,765 Tata Power Co Ltd (Utilities)
Equity, Since 29 Feb 24 | 5004003% ₹29 Cr 724,927 Avalon Technologies Ltd (Technology)
Equity, Since 31 Jul 23 | AVALON3% ₹26 Cr 310,615
↓ -6,871 Mahindra Lifespace Developers Ltd (Real Estate)
Equity, Since 30 Jun 24 | MAHLIFE2% ₹25 Cr 666,245 3. Motilal Oswal Long Term Equity Fund
Motilal Oswal Long Term Equity Fund
Growth Launch Date 21 Jan 15 NAV (05 Sep 25) ₹50.7266 ↓ -0.13 (-0.26 %) Net Assets (Cr) ₹4,402 on 31 Jul 25 Category Equity - ELSS AMC Motilal Oswal Asset Management Co. Ltd Rating Risk Moderately High Expense Ratio 1.65 Sharpe Ratio 0.04 Information Ratio 0.92 Alpha Ratio 11.36 Min Investment 500 Min SIP Investment 500 Exit Load NIL Growth of 10,000 investment over the years.
Date Value 31 Aug 20 ₹10,000 31 Aug 21 ₹16,372 31 Aug 22 ₹16,008 31 Aug 23 ₹19,372 31 Aug 24 ₹31,421 31 Aug 25 ₹29,948 Returns for Motilal Oswal Long Term Equity Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 5 Sep 25 Duration Returns 1 Month -1.7% 3 Month -2.6% 6 Month 18.9% 1 Year -3.4% 3 Year 24.2% 5 Year 25% 10 Year 15 Year Since launch 16.5% Historical performance (Yearly) on absolute basis
Year Returns 2024 47.7% 2023 37% 2022 1.8% 2021 32.1% 2020 8.8% 2019 13.2% 2018 -8.7% 2017 44% 2016 12.5% 2015 Fund Manager information for Motilal Oswal Long Term Equity Fund
Name Since Tenure Ajay Khandelwal 11 Dec 23 1.73 Yr. Rakesh Shetty 22 Nov 22 2.78 Yr. Atul Mehra 1 Oct 24 0.92 Yr. Data below for Motilal Oswal Long Term Equity Fund as on 31 Jul 25
Equity Sector Allocation
Sector Value Industrials 31.5% Financial Services 22.55% Consumer Cyclical 17.85% Technology 11.38% Basic Materials 5.89% Real Estate 4.55% Health Care 3.01% Communication Services 1.57% Asset Allocation
Asset Class Value Cash 1.68% Equity 98.32% Top Securities Holdings / Portfolio
Name Holding Value Quantity Eternal Ltd (Consumer Cyclical)
Equity, Since 31 Oct 23 | 5433206% ₹276 Cr 8,970,581 Prestige Estates Projects Ltd (Real Estate)
Equity, Since 31 Oct 23 | PRESTIGE5% ₹200 Cr 1,231,856
↑ 176,651 Amber Enterprises India Ltd Ordinary Shares (Consumer Cyclical)
Equity, Since 31 Mar 24 | AMBER4% ₹191 Cr 240,350 Multi Commodity Exchange of India Ltd (Financial Services)
Equity, Since 29 Feb 24 | MCX4% ₹191 Cr 248,438 Kaynes Technology India Ltd (Industrials)
Equity, Since 30 Jun 23 | KAYNES4% ₹179 Cr 289,593
↓ -8,158 Bharat Dynamics Ltd Ordinary Shares (Industrials)
Equity, Since 31 Dec 23 | BDL4% ₹171 Cr 1,056,315 Gujarat Fluorochemicals Ltd Ordinary Shares (Basic Materials)
Equity, Since 28 Feb 23 | FLUOROCHEM4% ₹155 Cr 430,073
↑ 12,083 Suzlon Energy Ltd (Industrials)
Equity, Since 31 Jan 24 | SUZLON3% ₹152 Cr 24,702,337 Bharat Electronics Ltd (Industrials)
Equity, Since 30 Apr 24 | BEL3% ₹147 Cr 3,832,775
↓ -117,225 Piramal Enterprises Ltd (Financial Services)
Equity, Since 31 Jul 24 | 5003023% ₹146 Cr 1,168,384 4. Motilal Oswal Multicap 35 Fund
Motilal Oswal Multicap 35 Fund
Growth Launch Date 28 Apr 14 NAV (05 Sep 25) ₹62.3262 ↓ -0.17 (-0.28 %) Net Assets (Cr) ₹13,727 on 31 Jul 25 Category Equity - Multi Cap AMC Motilal Oswal Asset Management Co. Ltd Rating ☆☆☆☆☆ Risk Moderately High Expense Ratio 1.77 Sharpe Ratio 0.11 Information Ratio 0.8 Alpha Ratio 10.18 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Aug 20 ₹10,000 31 Aug 21 ₹14,206 31 Aug 22 ₹13,436 31 Aug 23 ₹15,316 31 Aug 24 ₹23,632 31 Aug 25 ₹24,334 Returns for Motilal Oswal Multicap 35 Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 5 Sep 25 Duration Returns 1 Month 0.2% 3 Month 3.7% 6 Month 13.6% 1 Year 3.6% 3 Year 22.4% 5 Year 19.8% 10 Year 15 Year Since launch 17.5% Historical performance (Yearly) on absolute basis
Year Returns 2024 45.7% 2023 31% 2022 -3% 2021 15.3% 2020 10.3% 2019 7.9% 2018 -7.8% 2017 43.1% 2016 8.5% 2015 14.6% Fund Manager information for Motilal Oswal Multicap 35 Fund
Name Since Tenure Ajay Khandelwal 1 Oct 24 0.92 Yr. Niket Shah 1 Jul 22 3.17 Yr. Rakesh Shetty 22 Nov 22 2.78 Yr. Atul Mehra 1 Oct 24 0.92 Yr. Sunil Sawant 1 Jul 24 1.17 Yr. Data below for Motilal Oswal Multicap 35 Fund as on 31 Jul 25
Equity Sector Allocation
Sector Value Technology 30.71% Industrials 20.55% Consumer Cyclical 16.57% Financial Services 9.39% Communication Services 8.31% Utility 5.9% Health Care 1.82% Asset Allocation
Asset Class Value Cash 6.74% Equity 93.26% Top Securities Holdings / Portfolio
Name Holding Value Quantity Coforge Ltd (Technology)
Equity, Since 31 May 23 | COFORGE10% ₹1,400 Cr 8,005,911
↓ -119,089 Polycab India Ltd (Industrials)
Equity, Since 31 Jan 24 | POLYCAB10% ₹1,364 Cr 2,000,000 Dixon Technologies (India) Ltd (Technology)
Equity, Since 31 Mar 25 | DIXON10% ₹1,347 Cr 800,000
↑ 175,000 Kalyan Jewellers India Ltd (Consumer Cyclical)
Equity, Since 30 Sep 23 | KALYANKJIL9% ₹1,189 Cr 20,000,000
↑ 2,000,000 Persistent Systems Ltd (Technology)
Equity, Since 31 Mar 23 | PERSISTENT9% ₹1,187 Cr 2,300,000
↑ 100,000 Trent Ltd (Consumer Cyclical)
Equity, Since 31 Jan 23 | 5002517% ₹1,004 Cr 2,000,000 CG Power & Industrial Solutions Ltd (Industrials)
Equity, Since 31 Jan 25 | 5000937% ₹893 Cr 13,499,862
↑ 1,249,862 Siemens Energy India Ltd (Utilities)
Equity, Since 30 Jun 25 | ENRIN6% ₹809 Cr 2,500,000
↑ 49,500 Cholamandalam Investment and Finance Co Ltd (Financial Services)
Equity, Since 31 Mar 23 | CHOLAFIN5% ₹722 Cr 5,000,000
↑ 500,000 Bharti Airtel Ltd (Partly Paid Rs.1.25) (Communication Services)
Equity, Since 30 Apr 24 | 8901575% ₹720 Cr 4,999,500 5. Invesco India Mid Cap Fund
Invesco India Mid Cap Fund
Growth Launch Date 19 Apr 07 NAV (05 Sep 25) ₹180.34 ↑ 0.78 (0.43 %) Net Assets (Cr) ₹7,802 on 31 Jul 25 Category Equity - Mid Cap AMC Invesco Asset Management (India) Private Ltd Rating ☆☆ Risk Moderately High Expense Ratio 1.82 Sharpe Ratio 0.32 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Aug 20 ₹10,000 31 Aug 21 ₹15,770 31 Aug 22 ₹16,877 31 Aug 23 ₹20,541 31 Aug 24 ₹31,641 31 Aug 25 ₹33,990 Returns for Invesco India Mid Cap Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 5 Sep 25 Duration Returns 1 Month 1.1% 3 Month 4.1% 6 Month 23.8% 1 Year 8.7% 3 Year 26.9% 5 Year 28.1% 10 Year 15 Year Since launch 17% Historical performance (Yearly) on absolute basis
Year Returns 2024 43.1% 2023 34.1% 2022 0.5% 2021 43.1% 2020 24.4% 2019 3.8% 2018 -5.3% 2017 44.3% 2016 1.1% 2015 6.4% Fund Manager information for Invesco India Mid Cap Fund
Name Since Tenure Aditya Khemani 9 Nov 23 1.81 Yr. Amit Ganatra 1 Sep 23 2 Yr. Data below for Invesco India Mid Cap Fund as on 31 Jul 25
Equity Sector Allocation
Sector Value Financial Services 29.43% Health Care 19.75% Consumer Cyclical 16.17% Industrials 10.06% Real Estate 7.86% Technology 7.74% Basic Materials 5.42% Communication Services 1.65% Asset Allocation
Asset Class Value Cash 1.92% Equity 98.08% Top Securities Holdings / Portfolio
Name Holding Value Quantity BSE Ltd (Financial Services)
Equity, Since 31 Dec 23 | BSE5% ₹369 Cr 1,519,233 Glenmark Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Mar 24 | 5322965% ₹358 Cr 1,676,417 Swiggy Ltd (Consumer Cyclical)
Equity, Since 30 Nov 24 | SWIGGY5% ₹353 Cr 8,755,404
↑ 957,513 L&T Finance Ltd (Financial Services)
Equity, Since 31 Dec 23 | LTF4% ₹341 Cr 16,854,973 Prestige Estates Projects Ltd (Real Estate)
Equity, Since 30 Nov 23 | PRESTIGE4% ₹330 Cr 2,031,622 JK Cement Ltd (Basic Materials)
Equity, Since 31 Oct 22 | JKCEMENT4% ₹308 Cr 463,277
↑ 32,043 Max Financial Services Ltd (Financial Services)
Equity, Since 30 Nov 23 | 5002714% ₹303 Cr 2,016,896
↑ 174,838 The Federal Bank Ltd (Financial Services)
Equity, Since 31 Oct 22 | FEDERALBNK4% ₹295 Cr 14,592,638
↑ 1,181,051 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Dec 22 | MAXHEALTH4% ₹280 Cr 2,246,434 Dixon Technologies (India) Ltd (Technology)
Equity, Since 28 Feb 22 | DIXON3% ₹262 Cr 155,335 6. UTI Healthcare Fund
UTI Healthcare Fund
Growth Launch Date 28 Jun 99 NAV (05 Sep 25) ₹293.129 ↑ 0.60 (0.21 %) Net Assets (Cr) ₹1,146 on 31 Jul 25 Category Equity - Sectoral AMC UTI Asset Management Company Ltd Rating ☆ Risk High Expense Ratio 2.26 Sharpe Ratio 0.43 Information Ratio -0.06 Alpha Ratio 0.67 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Aug 20 ₹10,000 31 Aug 21 ₹14,183 31 Aug 22 ₹12,385 31 Aug 23 ₹15,093 31 Aug 24 ₹23,487 31 Aug 25 ₹24,105 Returns for UTI Healthcare Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 5 Sep 25 Duration Returns 1 Month 0.8% 3 Month 4.8% 6 Month 15.2% 1 Year 2.6% 3 Year 25.7% 5 Year 19.1% 10 Year 15 Year Since launch 15% Historical performance (Yearly) on absolute basis
Year Returns 2024 42.9% 2023 38.2% 2022 -12.3% 2021 19.1% 2020 67.4% 2019 1.2% 2018 -7.5% 2017 6.2% 2016 -9.7% 2015 12.4% Fund Manager information for UTI Healthcare Fund
Name Since Tenure Kamal Gada 2 May 22 3.34 Yr. Data below for UTI Healthcare Fund as on 31 Jul 25
Equity Sector Allocation
Sector Value Health Care 96.62% Basic Materials 1.03% Asset Allocation
Asset Class Value Cash 2.34% Equity 97.66% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMA10% ₹113 Cr 661,016 Cipla Ltd (Healthcare)
Equity, Since 31 Jan 03 | 5000875% ₹62 Cr 400,000 Ajanta Pharma Ltd (Healthcare)
Equity, Since 31 Jul 17 | 5323315% ₹55 Cr 200,000
↓ -10,000 Lupin Ltd (Healthcare)
Equity, Since 28 Feb 25 | 5002574% ₹49 Cr 255,000
↑ 55,000 Procter & Gamble Health Ltd (Healthcare)
Equity, Since 31 Dec 20 | PGHL4% ₹47 Cr 80,283 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | DRREDDY4% ₹46 Cr 360,000 Glenmark Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Mar 24 | 5322964% ₹41 Cr 190,000
↓ -60,000 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Dec 20 | 5328433% ₹40 Cr 465,000 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Apr 21 | APOLLOHOSP3% ₹40 Cr 53,000 Gland Pharma Ltd (Healthcare)
Equity, Since 30 Nov 20 | GLAND3% ₹34 Cr 166,863
↓ -13,137 7. SBI Healthcare Opportunities Fund
SBI Healthcare Opportunities Fund
Growth Launch Date 31 Dec 04 NAV (04 Sep 25) ₹432.494 ↑ 0.13 (0.03 %) Net Assets (Cr) ₹4,027 on 31 Jul 25 Category Equity - Sectoral AMC SBI Funds Management Private Limited Rating ☆☆ Risk High Expense Ratio 1.97 Sharpe Ratio 0.6 Information Ratio 0.38 Alpha Ratio 3.04 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-15 Days (0.5%),15 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Aug 20 ₹10,000 31 Aug 21 ₹14,180 31 Aug 22 ₹12,913 31 Aug 23 ₹16,856 31 Aug 24 ₹24,718 31 Aug 25 ₹25,879 Returns for SBI Healthcare Opportunities Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 5 Sep 25 Duration Returns 1 Month -0.5% 3 Month 3.5% 6 Month 11.4% 1 Year 5% 3 Year 26.7% 5 Year 21% 10 Year 15 Year Since launch 15.5% Historical performance (Yearly) on absolute basis
Year Returns 2024 42.2% 2023 38.2% 2022 -6% 2021 20.1% 2020 65.8% 2019 -0.5% 2018 -9.9% 2017 2.1% 2016 -14% 2015 27.1% Fund Manager information for SBI Healthcare Opportunities Fund
Name Since Tenure Tanmaya Desai 1 Jun 11 14.26 Yr. Data below for SBI Healthcare Opportunities Fund as on 31 Jul 25
Equity Sector Allocation
Sector Value Health Care 91.66% Basic Materials 5.96% Asset Allocation
Asset Class Value Cash 2.31% Equity 97.62% Debt 0.07% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Dec 17 | SUNPHARMA11% ₹461 Cr 2,700,000
↓ -100,000 Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB7% ₹290 Cr 440,000 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Mar 21 | MAXHEALTH6% ₹262 Cr 2,100,000 Cipla Ltd (Healthcare)
Equity, Since 31 Aug 16 | 5000875% ₹187 Cr 1,200,000 Lonza Group Ltd ADR (Healthcare)
Equity, Since 31 Jan 24 | LZAGY4% ₹165 Cr 270,000
↓ -30,000 Lupin Ltd (Healthcare)
Equity, Since 31 Aug 23 | 5002574% ₹162 Cr 840,000 Gland Pharma Ltd (Healthcare)
Equity, Since 30 Nov 20 | GLAND4% ₹145 Cr 700,000
↑ 160,000 Mankind Pharma Ltd (Healthcare)
Equity, Since 30 Apr 23 | MANKIND4% ₹144 Cr 560,000 Acutaas Chemicals Ltd (Basic Materials)
Equity, Since 30 Jun 24 | 5433493% ₹133 Cr 1,000,000 Krishna Institute of Medical Sciences Ltd (Healthcare)
Equity, Since 30 Nov 22 | 5433083% ₹131 Cr 1,750,000
↓ -50,000 8. TATA India Pharma & Healthcare Fund
TATA India Pharma & Healthcare Fund
Growth Launch Date 28 Dec 15 NAV (05 Sep 25) ₹30.7696 ↓ -0.03 (-0.09 %) Net Assets (Cr) ₹1,339 on 31 Jul 25 Category Equity - Sectoral AMC Tata Asset Management Limited Rating Risk High Expense Ratio 2.17 Sharpe Ratio 0.16 Information Ratio 0.6 Alpha Ratio 2.48 Min Investment 5,000 Min SIP Investment 150 Exit Load 0-3 Months (0.25%),3 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Aug 20 ₹10,000 31 Aug 21 ₹14,514 31 Aug 22 ₹12,943 31 Aug 23 ₹15,786 31 Aug 24 ₹24,599 31 Aug 25 ₹24,182 Returns for TATA India Pharma & Healthcare Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 5 Sep 25 Duration Returns 1 Month 0.8% 3 Month 4.1% 6 Month 12.6% 1 Year -1.1% 3 Year 23.8% 5 Year 19.3% 10 Year 15 Year Since launch 12.3% Historical performance (Yearly) on absolute basis
Year Returns 2024 40.4% 2023 36.6% 2022 -8% 2021 19.1% 2020 64.4% 2019 5.5% 2018 -2.6% 2017 4.7% 2016 -14.7% 2015 Fund Manager information for TATA India Pharma & Healthcare Fund
Name Since Tenure Rajat Srivastava 16 Sep 24 0.96 Yr. Data below for TATA India Pharma & Healthcare Fund as on 31 Jul 25
Equity Sector Allocation
Sector Value Health Care 91.69% Financial Services 1.63% Basic Materials 0.46% Asset Allocation
Asset Class Value Cash 6.22% Equity 93.78% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Jan 16 | SUNPHARMA11% ₹146 Cr 856,462
↑ 2,162 Cipla Ltd (Healthcare)
Equity, Since 30 Apr 20 | 5000877% ₹89 Cr 569,903
↑ 79,903 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 31 Dec 16 | APOLLOHOSP5% ₹70 Cr 92,826
↓ -34,429 Lupin Ltd (Healthcare)
Equity, Since 30 Nov 17 | 5002575% ₹64 Cr 330,887
↑ 27,647 HealthCare Global Enterprises Ltd (Healthcare)
Equity, Since 31 Dec 18 | HCG4% ₹59 Cr 942,453
↑ 276,332 Torrent Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Aug 22 | TORNTPHARM4% ₹58 Cr 154,717
↑ 83,796 Aster DM Healthcare Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Dec 22 | ASTERDM4% ₹58 Cr 956,991 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Oct 20 | 5328434% ₹54 Cr 624,597
↓ -230,503 Alkem Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 20 | ALKEM4% ₹54 Cr 106,435
↑ 31,186 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Jul 25 | MAXHEALTH4% ₹51 Cr 407,917
↑ 407,917 9. IDBI Small Cap Fund
IDBI Small Cap Fund
Growth Launch Date 21 Jun 17 NAV (05 Sep 25) ₹30.2874 ↑ 0.09 (0.30 %) Net Assets (Cr) ₹618 on 31 Jul 25 Category Equity - Small Cap AMC IDBI Asset Management Limited Rating Risk Moderately High Expense Ratio 2.3 Sharpe Ratio -0.45 Information Ratio -0.66 Alpha Ratio -3.3 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-12 Months (1%),12 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Aug 20 ₹10,000 31 Aug 21 ₹17,956 31 Aug 22 ₹21,516 31 Aug 23 ₹24,879 31 Aug 24 ₹38,550 31 Aug 25 ₹33,751 Returns for IDBI Small Cap Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 5 Sep 25 Duration Returns 1 Month 1.1% 3 Month 1.6% 6 Month 15.1% 1 Year -10.6% 3 Year 16.7% 5 Year 27.9% 10 Year 15 Year Since launch 14.5% Historical performance (Yearly) on absolute basis
Year Returns 2024 40% 2023 33.4% 2022 2.4% 2021 64.7% 2020 19% 2019 -4.4% 2018 -15% 2017 2016 2015 Fund Manager information for IDBI Small Cap Fund
Name Since Tenure Nikhil Rungta 1 Jul 24 1.17 Yr. Mahesh Bendre 1 Jul 24 1.17 Yr. Data below for IDBI Small Cap Fund as on 31 Jul 25
Equity Sector Allocation
Sector Value Industrials 31.47% Consumer Cyclical 14.94% Basic Materials 11.99% Consumer Defensive 7.79% Financial Services 6.74% Utility 6.52% Technology 6.07% Health Care 4.1% Communication Services 1.54% Real Estate 0.07% Asset Allocation
Asset Class Value Cash 8.77% Equity 91.23% Top Securities Holdings / Portfolio
Name Holding Value Quantity Concord Enviro Systems Ltd (Utilities)
Equity, Since 31 Dec 24 | CEWATER3% ₹17 Cr 270,441 Allied Blenders and Distillers Ltd (Consumer Defensive)
Equity, Since 31 Jul 24 | ABDL3% ₹17 Cr 326,140 Manorama Industries Ltd (Consumer Defensive)
Equity, Since 31 Dec 24 | 5419743% ₹17 Cr 109,106 JTL Industries Ltd (Basic Materials)
Equity, Since 31 Jul 24 | 5346002% ₹15 Cr 2,124,029
↓ -382,903 Navkar Corp Ltd (Industrials)
Equity, Since 31 Jul 24 | NAVKARCORP2% ₹15 Cr 1,130,075 Arvind Fashions Ltd (Consumer Cyclical)
Equity, Since 29 Feb 24 | ARVINDFASN2% ₹14 Cr 259,739
↑ 28,679 Housing & Urban Development Corp Ltd (Financial Services)
Equity, Since 31 Oct 24 | HUDCO2% ₹14 Cr 668,754 Apollo Micro Systems Ltd Ordinary Shares (Industrials)
Equity, Since 30 Jun 25 | APOLLO2% ₹14 Cr 877,192 Syrma SGS Technology Ltd (Technology)
Equity, Since 31 May 25 | SYRMA2% ₹14 Cr 180,780
↑ 9,031 International Gemmological Institute (India) Ltd (Basic Materials)
Equity, Since 31 Dec 24 | IGIL2% ₹13 Cr 337,832 10. Bandhan Infrastructure Fund
Bandhan Infrastructure Fund
Growth Launch Date 8 Mar 11 NAV (05 Sep 25) ₹49.237 ↓ -0.08 (-0.15 %) Net Assets (Cr) ₹1,676 on 31 Jul 25 Category Equity - Sectoral AMC IDFC Asset Management Company Limited Rating ☆☆☆☆☆ Risk High Expense Ratio 2.1 Sharpe Ratio -0.69 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 100 Exit Load 0-365 Days (1%),365 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Aug 20 ₹10,000 31 Aug 21 ₹19,221 31 Aug 22 ₹20,185 31 Aug 23 ₹26,032 31 Aug 24 ₹45,976 31 Aug 25 ₹39,818 Returns for Bandhan Infrastructure Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 5 Sep 25 Duration Returns 1 Month -1.4% 3 Month -2.5% 6 Month 15.7% 1 Year -11.7% 3 Year 25.9% 5 Year 32.3% 10 Year 15 Year Since launch 11.6% Historical performance (Yearly) on absolute basis
Year Returns 2024 39.3% 2023 50.3% 2022 1.7% 2021 64.8% 2020 6.3% 2019 -5.3% 2018 -25.9% 2017 58.7% 2016 10.7% 2015 -0.2% Fund Manager information for Bandhan Infrastructure Fund
Name Since Tenure Vishal Biraia 24 Jan 24 1.6 Yr. Ritika Behera 7 Oct 23 1.9 Yr. Gaurav Satra 7 Jun 24 1.24 Yr. Data below for Bandhan Infrastructure Fund as on 31 Jul 25
Equity Sector Allocation
Sector Value Industrials 52.91% Utility 12.23% Basic Materials 7.2% Communication Services 4.75% Energy 3.76% Financial Services 3.28% Health Care 2.19% Technology 1.74% Consumer Cyclical 1.38% Real Estate 1.08% Asset Allocation
Asset Class Value Cash 9.47% Equity 90.53% Top Securities Holdings / Portfolio
Name Holding Value Quantity Kirloskar Brothers Ltd (Industrials)
Equity, Since 31 Dec 17 | KIRLOSBROS5% ₹87 Cr 443,385 Larsen & Toubro Ltd (Industrials)
Equity, Since 29 Feb 12 | LT4% ₹75 Cr 206,262 Bharti Airtel Ltd (Communication Services)
Equity, Since 30 Apr 19 | BHARTIARTL4% ₹63 Cr 330,018 Reliance Industries Ltd (Energy)
Equity, Since 30 Jun 24 | RELIANCE4% ₹63 Cr 452,706 UltraTech Cement Ltd (Basic Materials)
Equity, Since 31 Mar 14 | 5325384% ₹61 Cr 49,772
↓ -680 GPT Infraprojects Ltd (Industrials)
Equity, Since 30 Nov 17 | GPTINFRA4% ₹61 Cr 4,733,244
↓ -49,289 Bharat Electronics Ltd (Industrials)
Equity, Since 31 Oct 19 | BEL3% ₹55 Cr 1,431,700 PTC India Financial Services Ltd (Financial Services)
Equity, Since 31 Dec 23 | PFS3% ₹52 Cr 12,400,122 Adani Ports & Special Economic Zone Ltd (Industrials)
Equity, Since 31 Dec 23 | ADANIPORTS3% ₹50 Cr 365,137 Ahluwalia Contracts (India) Ltd (Industrials)
Equity, Since 30 Apr 15 | AHLUCONT3% ₹47 Cr 462,606
এখানে প্রদত্ত তথ্যগুলি নির্ভুল নিশ্চিত করার জন্য সমস্ত প্রচেষ্টা করা হয়েছে। তবে তথ্যের সঠিকতা সম্পর্কিত কোনও গ্যারান্টি দেওয়া হয় না। কোনও বিনিয়োগ করার আগে দয়া করে স্কিম তথ্য নথি দিয়ে যাচাই করুন।
AMFI Registration No. 112358 | CIN: U74999MH2016PTC282153
Shepard Technologies Pvt. Ltd. (with ARN code 112358) makes no warranties or representations, express or implied, on products offered through the platform. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Terms and conditions of the website are applicable.
©2025 Shepard Technologies Private Limited. All Rights Reserved
Research Highlights for Motilal Oswal Midcap 30 Fund